Fera launches erythromycin ophthalmic ointment

NEW YORK Fera Pharmaceuticals has launched a treatment for bacterial infections of the eye, the generic drug maker announced Tuesday.

Fera said it had begun shipping erythromycin ophthalmic ointment in 1-g doses and would soon have the 3.5-g tube size available.

“Fera has made the completion of erythromycin 1-g manufacturing transfer a priority, responding to the market shortage,” Fera president Frank DellaFera said. “We are genuinely pleased to be able to help hospitals provide the standard of care they demand.”

Login or Register to post a comment.